Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Safety and immunogenicity of a candidate parvovirus B19 vaccine.

Bernstein DI, El Sahly HM, Keitel WA, Wolff M, Simone G, Segawa C, Wong S, Shelly D, Young NS, Dempsey W.

Vaccine. 2011 Oct 6;29(43):7357-63. doi: 10.1016/j.vaccine.2011.07.080. Epub 2011 Jul 30.

2.

Generation of a parvovirus B19 vaccine candidate.

Chandramouli S, Medina-Selby A, Coit D, Schaefer M, Spencer T, Brito LA, Zhang P, Otten G, Mandl CW, Mason PW, Dormitzer PR, Settembre EC.

Vaccine. 2013 Aug 20;31(37):3872-8. doi: 10.1016/j.vaccine.2013.06.062. Epub 2013 Jul 2.

PMID:
23827313
3.

Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1.

Ballou WR, Reed JL, Noble W, Young NS, Koenig S.

J Infect Dis. 2003 Feb 15;187(4):675-8. Epub 2003 Feb 7.

5.

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine.

Harro CD, Pang YY, Roden RB, Hildesheim A, Wang Z, Reynolds MJ, Mast TC, Robinson R, Murphy BR, Karron RA, Dillner J, Schiller JT, Lowy DR.

J Natl Cancer Inst. 2001 Feb 21;93(4):284-92.

7.

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico.

López-Macías C, Ferat-Osorio E, Tenorio-Calvo A, Isibasi A, Talavera J, Arteaga-Ruiz O, Arriaga-Pizano L, Hickman SP, Allende M, Lenhard K, Pincus S, Connolly K, Raghunandan R, Smith G, Glenn G.

Vaccine. 2011 Oct 13;29(44):7826-34. doi: 10.1016/j.vaccine.2011.07.099. Epub 2011 Aug 2.

PMID:
21816199
8.

Candidate recombinant vaccine for human B19 parvovirus.

Bansal GP, Hatfield JA, Dunn FE, Kramer AA, Brady F, Riggin CH, Collett MS, Yoshimoto K, Kajigaya S, Young NS.

J Infect Dis. 1993 May;167(5):1034-44.

PMID:
8486937
9.

Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins.

Gigler A, Dorsch S, Hemauer A, Williams C, Kim S, Young NS, Zolla-Pazner S, Wolf H, Gorny MK, Modrow S.

J Virol. 1999 Mar;73(3):1974-9.

10.

Symptoms associated with parvovirus B19 infection in adults: a pilot study.

Waza K, Inoue K, Matsumura S.

Intern Med. 2007;46(24):1975-8. Epub 2007 Dec 17.

11.

B19 parvovirus.

Young NS.

Baillieres Clin Haematol. 1995 Mar;8(1):25-56. Review.

PMID:
7663050
12.

Erythematous exanthem associated with primary infection by human parvovirus B19.

Veraldi S, Rizzitelli G.

Int J Dermatol. 1995 Feb;34(2):119. No abstract available.

PMID:
7737770
13.
14.

Parvovirus B19 infection.

Kerr JR.

Eur J Clin Microbiol Infect Dis. 1996 Jan;15(1):10-29. Review.

PMID:
8641299
15.

Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women.

Fife KH, Wheeler CM, Koutsky LA, Barr E, Brown DR, Schiff MA, Kiviat NB, Jansen KU, Barber H, Smith JF, Tadesse A, Giacoletti K, Smith PR, Suhr G, Johnson DA.

Vaccine. 2004 Jul 29;22(21-22):2943-52.

PMID:
15246631
16.

Impaired gamma interferon responses against parvovirus B19 by recently infected children.

Corcoran A, Doyle S, Waldron D, Nicholson A, Mahon BP.

J Virol. 2000 Nov;74(21):9903-10.

17.

Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy.

Dobec M, Juchler A, Flaviano A, Kaeppeli F.

Gynecol Obstet Invest. 2007;63(1):53-4. Epub 2006 Aug 25.

PMID:
16940737
18.

Antibody responses in parvovirus B19 infected patients.

Modrow S, Dorsch S.

Pathol Biol (Paris). 2002 Jun;50(5):326-31. Review.

PMID:
12116851
19.

[Parvovirus B19 infection: the general aspects and gestational problems].

Di Stefano L, Carta G, Barnabei R, Tomei E, Toro G, Moscarini M.

Minerva Ginecol. 1995 Apr;47(4):121-5. Italian.

PMID:
7644092
20.

Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection.

Kerr JR, Coyle PV, DeLeys RJ, Patterson CC.

J Med Virol. 1996 Jan;48(1):68-75.

PMID:
8825713
Items per page

Supplemental Content

Write to the Help Desk